Bis(2-methoxyethyl)aminosulfur trifluoride | CAS:202289-38-1

We serve Bis(2-methoxyethyl)aminosulfur trifluoride CAS:202289-38-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Bis(2-methoxyethyl)aminosulfur trifluoride

Chemical Name:Bis(2-methoxyethyl)aminosulfur trifluoride
CAS.NO:202289-38-1
Synonyms:Bis(2-methoxyethyl)aminosulfur trifluoride;BAST;Deoxo-Fluor
Molecular Formula:C6H14F3NO2S
Molecular Weight:221.2410696
 
Specification:
Density:1.2;       
Boiling point:80oC;
Flash point:205oC;  
Index of Refraction:1.392;
 
Appearance:Yellow liquid
Assay :≥95.0%
Residue on ignition: ≤0.1%
Moisture :≤0.1%



Contact us for information like Bis(2-methoxyethyl)aminosulfur trifluoride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Deoxo-Fluor physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,BAST Use and application,BAST technical grade,usp/ep/jp grade.


Related News: You will find the name and amount of the active ingredient contained in the medicine on the package of OTC (over-the-counter) drugs.11-Bromo-1-Undecene manufacturer You will find the name and amount of the active ingredient contained in the medicine on the package of OTC (over-the-counter) drugs.pyrrolidine supplier The KCDC said a 28-year-old man had tested positive. He was among the 368 repatriated South Koreans who arrived from Wuhan on a charter flight on January 31. The rest of the evacuees have tested negative for the coronavirus.4-chloro-N-methylpyridine-2-carboxamide,hydrochloride vendor These mathematical dosing algorithms were developed in the Damiano Lab at Boston University and refined based on results from home-use clinical trials in adults and children with T1D. Beta Bionics is a Certified B Corporation? whose founders — in addition to Ed Damiano — include other parents of children with type 1 diabetes and people with type 1 diabetes. Beta Bionics is committed to acting in the best interests of the diabetes community and to profoundly disrupting the diabetes medical device industry by bringing the iLet to market as expeditiously and responsibly as possible.These mathematical dosing algorithms were developed in the Damiano Lab at Boston University and refined based on results from home-use clinical trials in adults and children with T1D. Beta Bionics is a Certified B Corporation? whose founders — in addition to Ed Damiano — include other parents of children with type 1 diabetes and people with type 1 diabetes. Beta Bionics is committed to acting in the best interests of the diabetes community and to profoundly disrupting the diabetes medical device industry by bringing the iLet to market as expeditiously and responsibly as possible.